Subglottic Masses Revealing Rosai-Dorfman Disease
  • Mouna Snoussi
    Department of Internal Medicine, Hedi Chaker Hospital, Sfax, Tunisia
  • Abir Derbel
    Department of Internal Medicine, Hedi Chaker Hospital, Sfax, Tunisia
  • Yosr Hentati Hentati
    Department of Medical Imaging, Hedi Chaker Hospital, Sfax, Tunisia
  • Zeineb Mnif
    Department of Medical Imaging, Hedi Chaker Hospital, Sfax, Tunisia
  • Sameh Marzouk
    Department of Internal Medicine, Hedi Chaker Hospital, Sfax, Tunisia
  • Zouheir Bahloul
    Department of Internal Medicine, Hedi Chaker Hospital, Sfax, Tunisia


Rosai Dofmann disease, laryngeal involvement, steroids


Rosai-Dorfman disease (RDD) is an uncommon lymphoproliferative disorder; RDD with oropharyngeal involvement is extremely rare, especially in adults. A 65-year-old woman with a complaint of progressive dyspnoea since 2016 presented with laryngeal involvement of RDD. A laryngoscopy examination revealed two solid, polypoid masses in the subglottic region, and a laryngeal biopsy concluded chronic in ammation without signs of malignancy. A second biopsy of axillary lymph nodes was performed, supporting the diagnosis of histiocytosis. The patient was treated with corticosteroids and then lost to follow-up. In 2019, she suffered from dyspnoea and a hoarse voice. Laryngoscopy examination showed a polypoid lesion causing airway obstruction at 70% and thickening of the lateral wall of the cavum. Physical examination found left axillary and submandibular adenopathy, and computed tomography revealed thickening of the supraglottic larynx narrowing the laryngeal pathway. Lymphadenectomy with immunohistochemical analysis revealed typical protein positive S-100 histiocytes and emperipolesis. The patient was treated with high doses of corticosteroids for six weeks then these were progressively decreased. The outcome was favourable; the laryngeal lesion disappeared after two weeks of treatment.



  • Goodnight JW, Wang MB, Sercarz JA, Fu YS. Extranodal Rosai-Dorfman disease of the head and neck. Laryngoscope 1996;106(3 Pt 1):253–6. doi: 10.1097/00005537- 199603000-00002. PMID: 8614184.
  • Unal OF, Kocan EG, Sungur A, Kaya S. Rosai–Dorfman disease with multi-organ involvement in head and neck region. Int J PediatrOtorhinolaryngol 2004;68(5):581–4. doi: 10.1016/j.ijporl.2003.11.019. PMID: 15081232.
  • Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol 1990;7(1):19–73.
  • Carpenter RJ 3rd, Banks PM, McDonald TJ, Sanderson DR. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a case with respiratory tract
  • involvement. Laryngoscope 1978;88(12):1963–9.
  • Aluf P, Prestinari A, Ramponi A, Castri M, Pia F. Rosai-Dorfman disease of the larynx. J Laryngol Otol 2000;114(7):565–7.
  • Carbone A, Passannante A, Gloghini A, Devaney KO, Rinaldo A, Ferlito A. Review of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) of head and
  • neck. Ann Otol Rhinol Laryngol 1999;108(11 Pt 1):1095–1104.
  • Ensari S, Selccuk A, Dere H, Perez N, Dizbay-Sak S. Rosai-Dorfman disease presenting as laryngeal masses. Kulak Burun Bogaz Ihtis Derg 2008;18(2):110–114. PMID: 18628647.
  • Niu Y, Li Y, Wang J, Jin X, Yang D, Huo H, et al. Laryngeal Rosai-Dorfman disease (sinus histiocytosis with massive lymphadenopathy): a retrospective study of 5 cases. Biomed Res Int 2017;2017:8521818. doi: 10.1155/2017/8521818. Epub 2017 Jul 9. PMID: 28770226; PMCID: PMC5523292.
  • Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF, et al. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes
  • disease. Blood 2018;131(26):2877–2890. doi: 10.1182/blood-2018-03-839753. Epub 2018 May 2. PMID: 29720485; PMCID: PMC6024636.
  • Bruce-Brand C,Schneider J W, Schubert P. Rosai-Dorfman disease: an overview. J Clin Pathol 2020;73(11):697–705.
  • Hazarika P, Nayak DR, Balakrishnan R, Kundaje HG, Rao PL. Rosai-Dorfman disease of the subglottis. J Laryngol Otol 2000;114(12):970–3. doi: 10.1258/0022215001904491. PMID: 11177371.
  • Ma YL, Liang ZP, Xu SE, Yang, Z-H, Peng Y, Sun X-Q,et al. Rosai-Dorfman disease (RDD) in the paraglottic space: report of a case and review of literature. Int J Clin Exp Pathol 2015;8(10):13532–13538.
  • Xu X, Deng WT, Huang CZ, Wang J. Rosai-Dorfman disease in the larynx: report of a case and literature review. Nan Fang Yi Ke Da Xue Xue Bao 2018;38(2):125–129. doi:3969/j.issn.1673-4254.2018.02.01. PMID: 29502048; PMCID: PMC6743884
  • Jalil J, Dar NR, Sha que M. RosaiDorfman disease—a rare entity report of two cases with nodal and extranodal involvement. J Pak Med Assoc 2008;58(6):338–40. PMID:18988397.
  • Dong YJ, Mu J, Cai YR. Primary sinus histiocytosis of the trachea: a case report and review of literature. Zhonghua Jie He He Hu Xi Za Zh 2013;36(7):501–505.
  • Li W, Yang L. A new phenomenon of Rosai-Dorfman disease: half body stabbing pain accompanied by hypopharyngeal, laryngeal, and cervical lymph node lesions. Chin Med J
  • (Engl) 2019;132(18):2257–2258. doi: 10.1097/CM9.0000000000000430. PMID: 31490260; PMCID: PMC6797150.
  • Bernacer-Borja M, Blanco-Rodriguez M, Sanchez-Granados JM, Benitez-Fuentes R, Cazorla-Jimenez A, Rivas-Manga C. Sinus histiocytosis with massive lymphadenopathy
  • (Rosai-Dorfman disease): clinico-pathological study of three cases. Eur J Pediatr 2006;165(8):536–9. doi: 10.1007/s00431-006-0133-0. Epub 2006 Apr 19. PMID: 16622659.
  • Toguri D, Louie AV, Rizkalla K, Franklin J, Rodrigues G, Venkatesan V. Radiotherapy for steroid-resistant laryngeal Rosai-Dorfman disease. Curr Oncol 2011;18(3):e158-62. doi:10.3747/co.v18i3.761. PMID: 21655154; PMCID: PMC3108876.
  • Cossor F, Al-Khater AH, Doll DC. Laryngeal obstruction and hoarseness associated with Rosai-Dorfman disease. J Clin Oncol 2006;24(12):1953-5. doi: 10.1200/JCO.2005.02.1378. PMID: 16622273.
  • Chang LY, Kuo TT, Chan HL.ExtranodalRosai-Dorfman disease with cutaneous, ophthalmic and laryngeal involvement: report of a case treated with isotretinoin. Int J Dermatol2002;41(12):888-91. doi: 10.1046/j.1365-4362.2002.01675.x. PMID: 12492979.
  • Lima FB, Barcelos PS, Constaancio AP, Nogueira CD, Melo-Filho AA. Rosai-Dorfman disease with spontaneous resolution: case report of a child. Rev Bras Hematol Hemoter2011; 33(4):312–4.
  • Leighton SE, Gallimore AP. Extranodal sinus histiocytosis with massive lymphadenopathy affecting the subglottis and trachea. Histopathology 1994;24(4):393–4. doi:10.1111/his.1994.24.issue-4.
  • Asrar L, Facharzt EH, Haque I. Rosai-Dorfman disease: presenting as isolated extranodal involvement of larynx. Otolaryngol 1998;27(2):85–6.
  • Hazarika P, Nayak DR, Balakrishnan R,Kundaje HG, Rao PL. Rosai-Dorfman disease of the subglottis. Laryngol Otol 2000;114(12):970–3.
  • Talebi T, Johns MM 3rd, Sequeira J, Saba N. Rosai-Dorfman disease of the epiglottis. Clin Oncol 2007;25(16):2324–6. doi:10.1200/JCO.2006.10.4919.
  • Tseng YL, Lin YC, Lo CY, Liao LJ.Rosai-Dorfman disease of the subglottis diagnosed by ultrasound-guided ne-needle aspiration biopsy: a case report. J Clin Ultrasound
  • ;38(2):103–6. doi: 10.1002/jcu.20651. PMID: 19953629.
  • Barbalho CE, Vasconcelos DN, Ximenes Filho JA, Araripe AA, Ferreira FV. Rosai-Dorfman disease as a differential diagnosis in vocal cord ulceration. Braz J Otorhinolaryngol2010;76(6):795. doi: 10.1590/S1808-86942010000600021
  • Illing EA, Halum SL. Rosai-Dorfman disease with isolated laryngeal involvement. Ear Nose Throat J 2012;91(10):439–440. PMID: 23076853.
  • Fusconi M, Benincasa AT, Grasso M, de Vincentiis M. Rosai-Dorfman disease in the larynx. Ear Nose Throat J 2013;92(6): E66.
  • Gadde J, Anzilotti K, Liu X, Lacocca M, Liu A. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) of the true vocal cord. Del Med J 2014; 86(5):149–52.
  • Swain SK, Das A, Sahoo S, Baisakh MR, Sahu MC.An unusual presentation of extranodalRosai-Dorfman disease threatening the airway. Auris Nasus Larynx 2016;43(2):197–9. doi:10.1016/j.anl.2015.06.007.
  • Wei C, Zhou DB. Long-time remission of laryngeal Rosai-Dorfman disease with thalidomide: a report of three cases. Hematology 2021;26(1):552–555. doi:10.1080/16078454.2021.1941552. PMID: 34348601.
  • Views: 356
    PDF downloads: 279
    HTML downloads: 45

    Published: 2023-02-03
    Issue: 2023: Vol 10 No 1 (view)

    How to cite:
    Snoussi M, Derbel A, Hentati YH, Mnif Z, Marzouk S, Bahloul Z. Subglottic Masses Revealing Rosai-Dorfman Disease. EJCRIM 2023;10 doi:10.12890/2023_003389.

    Most read articles by the same author(s)